ClinicalTrials.govpublic full text
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
multiple sclerosis, relapsing-remitting, multiple sclerosis, relapsing-remitting, ozanimod, zeposia®, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 879442
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.